Hernday Natasha 4
4 · ALPINE IMMUNE SCIENCES, INC. · Filed Jan 4, 2024
Insider Transaction Report
Form 4
Hernday Natasha
Director
Transactions
- Award
Stock Option (Right to buy)
2024-01-02+17,500→ 17,500 totalExercise: $19.00Exp: 2034-01-01→ Common Stock (17,500 underlying)
Footnotes (2)
- [F1]The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant.
- [F2]1/12th of the shares subject to the option become vested and exercisable on February 2, 2024 and 1/12 of the shares subject to the option shall vest monthly thereafter.